Company
About Us
Leadership
Board of Directors
DDR Advisory Committee
Careers
Contact Us
Momelotinib
DNA Damage Response
Pipeline
Development Pipeline
Momelotinib
SRA737
SRA737
Targeting Chk1
Clinical Trials
Publications
SRA141
Expanded Access Policy
Investors
Investor Relations
News Releases
Events & Webcasts
Presentations
Publications
Financial Reporting
Stock Information
Corporate Governance
FAQs
Investor Alerts
company
About Us
Leadership
Board of Directors
Careers
Contact us
Science
Science Overview
DDR
Development
Development Overview
SRA737
SRA141
Investors
Investors Overview
News Release
Events & Webcasts
Presentations
Financial Reporting
Quarterly Results
Stock Information
Corporate Governance
FAQs
Investor Alerts
Careers
News
Contact
INVESTORS
NASDAQ: SRRA
NASDAQ: DNAI
Year
Trailing 12-Months
Calendar Year 2019
Calendar Year 2018
Calendar Year 2017
Calendar Year 2016
Calendar Year 2015
Calendar Year 2014
Calendar Year 2013
Calendar Year 2012
Calendar Year 2010
Calendar Year 2009
Calendar Year 2008
Calendar Year 2007
Calendar Year 2006
Calendar Year 2005
Calendar Year 2004
View
All Filings
Annual Filings
Quarterly Filings
Current Filings
Registration Statements
Section 16
Proxy & Information Statements
Other
Form
Description
Date
Format
Investor Relations
News Releases
Events & Webcasts
Presentations
Publications
Financial Reporting
Stock Information
Corporate Governance
FAQs
Investor Alerts
